Viktor, Johan, John Drovta, Dighed, Öhd

Chief Executive Officer

C-suiteM

FI·FIN-FSA

Modus Therapeutics Holding AB Modus Therapeutics Holding AB

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Viktor, Johan, John Drovta, Dighed, Öhd, Chief Executive Officer. Insider active across 2 companies, notably Modus Therapeutics Holding AB. In total, 1 filings have been published. The latest transaction was disclosed on 1 September 2025 — Purchase. Regulator: FIN-FSA. All data is openly available.

Declarations1 total

Executives●PurchaseMModus Therapeutics Holding AB29FIN-FSA

V

Viktor, Johan, John Drovta, Dighed, ÖhdVerkställande direktör (VD), Vice VD, Annan medlem i bolagets administrations-, lednings- eller kontrollorgan

€1m4,891,533 shares@ €0.28641.62% mcap100.0% of flow

BTU (betald tecknad unit)

FI:A003R901-1·1 Sept 2025

Ideal exit: 29 May 2026 (T+270)

FIN-FSA ↗

1 of 1 declaration

About Viktor, Johan, John Drovta, Dighed, Öhd

Viktor Drovta is the CEO of Modus Therapeutics Holding AB. He is responsible for the daily management of the company, which focuses on innovative treatments for chronic diseases. His leadership and expertise in strategy are essential for the success of the organization.